Fifty Hadassah International leaders, representing 29 nationalities from the four corners of the world, including 11 time zones, 25 countries, and 17 languages came together in Jerusalem on November 19th for three days for their first in-person meetings, since the start of the Covid pandemic. After an emotional reunion, The Hadassah International retreat began […]
Hadassah and Drug Giant Merck Launch MRNA Iniative To Fight Cancer
Pharmaceutical company Merck and Hadassah University Hospital in Jerusalem launched CanceRNA, which aims to use messenger-RNA technology to treat cancer Regine Shevach, the head of Merck’s Innovative Technologies Enablement Centre in Israel, has always believed in collaborations. “In the past, projects usually happened within the same industry,” she said. “Today, however, things have […]
Despite the best efforts of our medical caregivers, certain medical procedures can be painful or unpleasant. Do we just “grin and bear it,” or can we come up with better methods to mitigate the pain? Not if Hadassah Medical Organisation nurses can help it. At Hadassah we always put our patients’ wellbeing first. In our hospitals in Jerusalem, […]
HADASSAH EIN KEREM AND HADASSAH MOUNT SCOPUS NAMED ISRAEL’S BEST HOSPITALS
The Health Ministry’s report for 2020 places Hadassah Hospital Ein Kerem in first place in the major hospital category and Hadassah Hospital Mount Scopus at the top in the category of small-campus hospitals. Both received a maximum score of 10. The scoresheet takes into account a vast array of services. Among them are the ability […]
HADASSAH IS JERUSALEM’S FIRST PUBLIC BODY TO USE NATURAL GAS
‘Our patients and those around us will be able to breathe cleaner air and the economic savings will allow the hospital to expand the services’ it can provide to arriving patients. Hadassah-University Medical Centre, Ein Kerem, became the first public institution to operate with the help of natural gas last Tuesday evening. In a ceremony […]
Tatiana Zhelninova, the former chief Physician and Medical Director of Hadassah Medical Moscow in Skolkovo, is striving to bring Israel’s top doctors and best biotechnologies to the United Arab Emirates, thereby improving healthcare in the region. “For doctors, nurses and medical professors, nationality and race are not important,” she told The Jerusalem Post on Wednesday […]
Hadassah UK Appeal: New Rehabilitation Centre Technological Incubator
Hadassah UK’s Appeal supports the New Rehabilitation Centre Technological Incubator at Hadassah Hospital Mount Scopus The Rehabilitation Department at Hadassah Mount Scopus is the sole department for patients aged 16-100 in the greater Jerusalem area. This department covers diverse neurological and orthopaedic situations in at least 4 dominant languages. It is characterised by a multicultural […]
First in Israel: Hadassah’s New Innovative Treatment Corrects Irregular Heartbeat
For the first time in Israel, a surgical team at Hadassah Hospital Ein Kerem has performed an innovative procedure to treat an irregular heartbeat in a patient’s atrium that enables the surgeon to access areas of the heart that were either difficult or impossible to reach previously. The procedure destroys abnormal tissue with high-frequency electrical energy, rendering the dysfunctional tissue incapable […]
Hadassah’s Revolution in Scientific Research: What are Organoids?
Classically, researchers in basic medical science have had two tools: in vitro cultures and animal models. The limitations pose many challenges: Cells taken out of the human body and grown in a petri dish won’t behave exactly as they do within a real organ of the body. Animal models are not as highly complex as the human body. […]
Hadassah and Neurogenesis announce results from Phase 2 MS Study
A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat neurodegenerative diseases. The 14-month randomized, double blind, placebo-controlled study, comprised of 48 patients, was led by Prof. […]
